Taken together, these observations suggest that the suppression of BMP7 signalling due to loss of JAM-A may also increase β-catenin activity, thereby further promoting MIR21 transcription, sustaining JAM-A downregulation and promoting CRC progression. The gene discussed is BMP7; the disease is colorectal carcinoma.